(Q37535998)

20 August 2017

1 reference

title

Patented small molecules against psoriasis (English)

1 reference

20 August 2017

0 references

Alexander M Abdelnoor

series ordinal

1

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

Expert Opinion on Therapeutic Patents

20 August 2017

published in

1 reference

20 August 2017

volume

19

1 reference

20 August 2017

issue

8

1 reference

20 August 2017

page(s)

1057-1071

1 reference

Psoriasis: genetic associations and immune system changes.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

The pathogenesis of psoriasis: immunological facts and speculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

HLA allele associations and V-beta T-lymphocyte expansions in patients with psoriasis, harboring toxin-producing Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Recent developments in the understanding of the pathogenesis of psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

ELAM-1 is an adhesion molecule for skin-homing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

The IL-23/IL-17 axis in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Molecular characterization of CCR6: involvement of multiple domains in ligand binding and receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

IL-12-impaired and IL-12-secreting dendritic cells produce IL-23 upon CD154 restimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

IL-12, IL-23, and IL-27 enhance human beta-defensin-2 production in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Infliximab (Remicade) in the treatment of psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Triggering of T cell activation via CD4 dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

CD28/B7 system of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Structure-activity studies of a series of dipyrazolo[3,4-b:3',4'-d]pyridin-3-ones binding to the immune regulatory protein B7.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Bz-423 superoxide signals apoptosis via selective activation of JNK, Bak, and Bax

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

7-Chloro-5-(4-hydroxyphenyl)-1-methyl-3-(naphthalen-2-ylmethyl)-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one (Bz-423), a benzodiazepine, suppresses keratinocyte proliferation and has antipsoriatic activity in the human skin-severe, combined immuno

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Pirlindole: a selective reversible inhibitor of monoamine oxidase A. A review of its preclinical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

UBPY: a growth-regulated human ubiquitin isopeptidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Critical role for IL-15 in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Peptide T improves psoriasis when infused into lesions in nanogram amounts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Peptide T blocks GP120/CCR5 chemokine receptor-mediated chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Immunomodulatory effects of a set of amygdalin analogues on human keratinocyte cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Synthesis and evaluation of diverse analogs of amygdalin as potential peptidomimetics of peptide T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Amygdalin suppresses lipopolysaccharide-induced expressions of cyclooxygenase-2 and inducible nitric oxide synthase in mouse BV2 microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailabl

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Fucoidin, a potent inhibitor of leukocyte rolling, prevents neutrophil influx into phorbol-ester-induced inflammatory sites in rabbit lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Targeting selectin functions in the therapy of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Expression of cysteinyl leukotriene receptor-1 in skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Role of petasin in the potential anti-inflammatory activity of a plant extract of petasites hybridus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Design and synthesis of 4,5-diphenyl-4-isoxazolines: novel inhibitors of cyclooxygenase-2 with analgesic and antiinflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Phosphodiesterase inhibitors: Lily the Pink's medicinal compound for asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tar.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Valproic acid inhibits angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Rapid clearance of psoriatic skin lesions induced by topical cyclopamine. A preliminary proof of concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Psoriatic skin expresses the transcription factor Gli1: possible contribution of decreased neurofibromin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Lack of evidence for activation of the hedgehog pathway in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: accomplishments and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

The Mannich base NC1153 promotes long-term allograft survival and spares the recipient from multiple toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Naphthyl ketones: a new class of Janus kinase 3 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Immunobiology of Toll-like receptors: emerging trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Targeting toll-like receptors for drug development: a summary of commercial approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

21 January 2018

Bacterial superantigens

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

A Fas agonist induces high levels of apoptosis in haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

HA14-1, a small molecule Bcl-2 antagonist, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

CTLA-4 up-regulation plays a role in tolerance mediated by CD45.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903029201

10.1517/13543770903029201

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference